Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
3SBio (SSRX)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for SSRX as compared to
Top Competitors
Biotechnology
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
Net Income
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
40.7M
AVG
EBITDA
►
8.40M
HIGH
Net Income
►
6.31M
VERY HIGH
Revenue Growth
►
32%
AVG
Net Income Growth
►
-45.4%
LOW
Operating Margin
►
29.5%
HIGH
Net Margin
►
15.5%
HIGH
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.0380
VERY LOW
Current Ratio
►
25.8
VERY HIGH
Quick Ratio
►
25.5
VERY HIGH
Interest Coverage Ratio
►
827
VERY HIGH
Book Value Per Share
►
6.98
Cash Per Share
►
1.29
Loading...
STOCK SUMMARY
Open
Day Range
-
52 Week Range
-
Volume
Avg Volume (3 mo)
Shares Outstanding
Market Cap
VALUATION
Price to Earnings (P/E)
►
41.3
AVG
Price to Book (P/B)
►
1.84
AVG
Price to Sales (P/S)
►
6.40
AVG
Return on Assets (ROA)
►
4.4%
HIGH
Return on Equity (ROE)
►
4.5%
AVG
EV/EBITDA
►
34.1
HIGH
ANALYST RECOMMENDATIONS
OWNERSHIP
Held by institutions
5.7%